BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 38578472)

  • 1. Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM).
    Glezer A; Mendes Garmes H; Kasuki L; Martins M; Condé Lamparelli Elias P; Dos Santos Nunes Nogueira V; Rosa-E-Silva ACJS; Maciel GAR; Benetti-Pinto CL; Prestes Nácul A
    Arch Endocrinol Metab; 2024 Apr; 68():e230502. PubMed ID: 38578472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM).
    Benetti-Pinto CL; Prestes Nácul A; Rosa-E-Silva ACJS; Maciel GAR; Dos Santos Nunes Nogueira V; Condé Lamparelli Elias P; Martins M; Kasuki L; Mendes Garmes H; Glezer A
    Arch Endocrinol Metab; 2024 Apr; 68():e230504. PubMed ID: 38578473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
    Vilar L; Abucham J; Albuquerque JL; Araujo LA; Azevedo MF; Boguszewski CL; Casulari LA; Cunha Neto MBC; Czepielewski MA; Duarte FHG; Faria MDS; Gadelha MR; Garmes HM; Glezer A; Gurgel MH; Jallad RS; Martins M; Miranda PAC; Montenegro RM; Musolino NRC; Naves LA; Ribeiro-Oliveira Júnior A; Silva CMS; Viecceli C; Bronstein MD
    Arch Endocrinol Metab; 2018; 62(2):236-263. PubMed ID: 29768629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium.
    Hamblin R; Fountas A; Lithgow K; Loughrey PB; Bonanos E; Shinwari SK; Mitchell K; Shah S; Grixti L; Matheou M; Isand K; McLaren DS; Surya A; Ullah HZ; Klaucane K; Jayasuriya A; Bhatti S; Mavilakandy A; Ahsan M; Mathew S; Hussein Z; Jansz T; Wunna W; MacFarlane J; Ayuk J; Abraham P; Drake WM; Gurnell M; Brooke A; Baldeweg SE; Sam AH; Martin N; Higham C; Reddy N; Levy MJ; Ahluwalia R; Newell-Price J; Vamvakopoulos J; Krishnan A; Lansdown A; Murray RD; Pal A; Bradley K; Mamoojee Y; Purewal T; Panicker J; Freel EM; Hasan F; Kumar M; Jose B; Hunter SJ; Karavitaki N
    Eur J Endocrinol; 2023 Jul; 189(1):87-95. PubMed ID: 37345849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Presentations of Drug-Induced Hyperprolactinaemia: A Literature Review.
    Junqueira DR; Bennett D; Huh SY; Casañas I Comabella C
    Pharmaceut Med; 2023 Mar; 37(2):153-166. PubMed ID: 36800148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinemia after menopause: Diagnosis and management.
    Auriemma RS; Pirchio R; Pivonello R; Colao A
    Maturitas; 2021 Sep; 151():36-40. PubMed ID: 34446277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIP variant causing familial prolactinoma.
    Carty DM; Harte R; Drummond RS; Ward R; Magid K; Collier D; Owens M; Korbonits M
    Pituitary; 2021 Feb; 24(1):48-52. PubMed ID: 33010004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of silent acromegaly in prolactinomas is very low.
    Bona C; Prencipe N; Jaffrain-Rea ML; Carosi G; Lanzi R; Ambrosio MR; Pasquali D; Vettor R; Cannavò S; Ghigo E; Grottoli S
    J Endocrinol Invest; 2021 Mar; 44(3):531-539. PubMed ID: 32594452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinaemia.
    Samperi I; Lithgow K; Karavitaki N
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31847209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new.
    Chanson P; Maiter D
    Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101290. PubMed ID: 31326373
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.